{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1045.41",
  "meta": {
    "versionId": "29",
    "lastUpdated": "2021-03-17T15:52:19.000-04:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.41",
  "version": "20210220",
  "name": "Glycoprotein IIb/IIIa Inhibitors",
  "status": "active",
  "date": "2021-02-20T01:02:00-05:00",
  "publisher": "TJC EH Steward",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05022022",
        "concept": [
          {
            "code": "1736470",
            "display": "10 ML eptifibatide 2 MG/ML Injection"
          },
          {
            "code": "1736477",
            "display": "100 ML eptifibatide 2 MG/ML Injection"
          },
          {
            "code": "1737466",
            "display": "100 ML tirofiban 0.05 MG/ML Injection"
          },
          {
            "code": "1737471",
            "display": "250 ML tirofiban 0.05 MG/ML Injection"
          },
          {
            "code": "1813035",
            "display": "15 ML tirofiban 0.25 MG/ML Injection"
          },
          {
            "code": "200349",
            "display": "100 ML eptifibatide 0.75 MG/ML Injection"
          },
          {
            "code": "241162",
            "display": "5 ML abciximab 2 MG/ML Injection"
          }
        ]
      }
    ]
  }
}